HBV Antigen-Guided Switching Strategy From Nucleos(t)ide Analogue to Interferon: Avoid Virologic Breakthrough and Improve Functional Cure. Huang D, Yuan Z, Wu D, Yuan W, et al. J Med Virol 2024;96:e70021.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Huang D, Yuan Z, Wu D, Yuan W, et al. HBV Antigen-Guided Switching Strategy From Nucleos(t)ide Analogue to Interferon: Avoid Virologic Breakthrough and Improve Functional Cure. J Med Virol 2024;96:e70021.
PMID: 39530181